The pathways of Crohn's

Therapy for Crohn's disease is based on regimens of aminosalicylates, steroids, antibiotics, and periodic infusions of Remicade, an anti-TNF-alpha antibody marketed by Johnson & Johnson. But given the multitude of side effects and number of patients who do not respond to those treatments, more specific approaches are needed. While

Read the full 496 word article

User Sign In